300 related articles for article (PubMed ID: 2674099)
1. Inactivation of cefuroxime and cefotaxime by Bacteroides fragilis in vitro, and its influence on the treatment of an experimental Escherichia coli/Bacteroides fragilis mixed infection.
Beale AS; Gisby J
J Antimicrob Chemother; 1989 Jul; 24(1):29-37. PubMed ID: 2674099
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of amoxycillin/clavulanic acid in experimental Bacteroides fragilis/Escherichia coli mixed infections.
Beale AS; Gisby J; Sutherland R
J Antimicrob Chemother; 1988 Apr; 21(4):451-9. PubMed ID: 3288604
[TBL] [Abstract][Full Text] [Related]
3. Comparative efficacies of ticarcillin, ticarcillin/clavulanic acid, piperacillin and cefoxitin against polymicrobial infections in mice caused by Escherichia coli and Bacteroides fragilis.
Beale AS; Gisby J
Infection; 1991; 19(2):101-5. PubMed ID: 2050417
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacies of amoxicillin-clavulanic acid and ampicillin-sulbactam against experimental Bacteroides fragilis-Escherichia coli mixed infections.
Gisby J; Beale AS
Antimicrob Agents Chemother; 1988 Dec; 32(12):1830-3. PubMed ID: 3072924
[TBL] [Abstract][Full Text] [Related]
5. Effect of Bacteroides fragilis on mortality induced by Escherichia coli in an experimental infection treated with cefotaxime, aztreonam or gentamicin.
Soriano F; Ponte C; Santamaría M; Castilla C
J Antimicrob Chemother; 1989 Mar; 23(3):383-8. PubMed ID: 2659565
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of amoxycillin and benzylpenicillin combined with clavulanic acid against Bacteroides fragilis in vitro and in experimentally infected mice.
Dijkmans BA; Vaishnav J; Mattie H
Scand J Infect Dis; 1985; 17(3):311-21. PubMed ID: 3903976
[TBL] [Abstract][Full Text] [Related]
7. Levofloxacin plus metronidazole administered once daily versus moxifloxacin monotherapy against a mixed infection of Escherichia coli and Bacteroides fragilis in an in vitro pharmacodynamic model.
Hermsen ED; Hovde LB; Sprandel KA; Rodvold KA; Rotschafer JC
Antimicrob Agents Chemother; 2005 Feb; 49(2):685-9. PubMed ID: 15673752
[TBL] [Abstract][Full Text] [Related]
8. In-vitro activity of amoxycillin and ticarcillin in combination with clavulanic acid compared with that of new beta-lactam agents against species of the Bacteroides fragilis group.
Bourgault AM; Lamothe F
J Antimicrob Chemother; 1986 May; 17(5):593-603. PubMed ID: 3636324
[TBL] [Abstract][Full Text] [Related]
9. Pathogenicity of capsulate and non-capsulate members of Bacteroides fragilis and B. melaninogenicus groups in mixed infection with Escherichia coli and Streptococcus pyogenes.
Brook I
J Med Microbiol; 1988 Nov; 27(3):191-8. PubMed ID: 2903934
[TBL] [Abstract][Full Text] [Related]
10. Quantification of the effect of anti-anaerobic drugs in experimental Bacteroides fragilis infection in mice.
Dijkmans BA; Mattie H; Hermans J; van Furth R
J Antimicrob Chemother; 1984 Jan; 13(1):79-86. PubMed ID: 6365877
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against beta-lactamase-producing Bacteroides fragilis group.
García-Rodríguez JA; García Sánchez JE; Trujillano I; Muñoz-Bellido JL
J Chemother; 1990 Feb; 2(1):11-6. PubMed ID: 2332779
[TBL] [Abstract][Full Text] [Related]
12. beta-Lactamase produced by a highly beta-lactam-resistant strain of Bacteroides fragilis: an obstacle to the chemotherapy of experimental mixed infections.
Ajiki Y; Koga T; Ohya S; Takenouchi T; Yasuda H; Watanabe K; Ueno K
J Antimicrob Chemother; 1991 Oct; 28(4):537-46. PubMed ID: 1761449
[TBL] [Abstract][Full Text] [Related]
13. [Comparative bacteriostatic activity of ticarcillin, alone and combined with clavulanic acid, 5 cephalosporins and metronidazole against 100 strains of Bacteroides fragilis].
de Barbeyrac B; Quentin C; Bebear C
Pathol Biol (Paris); 1984 May; 32(5):433-5. PubMed ID: 6739151
[TBL] [Abstract][Full Text] [Related]
14. Combined activity of metronidazole and gentamicin on Bacteroides fragilis in vivo and in vitro.
Dijkmans BA; Vaishnav J; Mattie H
J Antimicrob Chemother; 1985 Jan; 15(1):77-82. PubMed ID: 3882656
[TBL] [Abstract][Full Text] [Related]
15. Beta-lactamase production, beta-lactam sensitivity and resistance to synergy with clavulanate of 737 Bacteroides fragilis group organisms from thirty-three US centres.
Jacobs MR; Spangler SK; Appelbaum PC
J Antimicrob Chemother; 1990 Sep; 26(3):361-70. PubMed ID: 2228827
[TBL] [Abstract][Full Text] [Related]
16. The treatment of irradiated mice with polymicrobial infection caused by Bacteroides fragilis and Escherichia coli.
Brook I; Ledney GD
J Antimicrob Chemother; 1994 Feb; 33(2):243-52. PubMed ID: 8182005
[TBL] [Abstract][Full Text] [Related]
17. Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
Rossi R; Castellani P; Younes G; Della Bruna C
J Antimicrob Chemother; 1989 Mar; 23 Suppl C():149-55. PubMed ID: 2732136
[TBL] [Abstract][Full Text] [Related]
18. In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.
Wise R; Andrews JM; Bedford KA
Antimicrob Agents Chemother; 1978 Mar; 13(3):389-93. PubMed ID: 122520
[TBL] [Abstract][Full Text] [Related]
19. In vivo efficacies of quinolones and clindamycin for treatment of infections with Bacteroides fragilis and/or Escherichia coli in mice: correlation with in vitro susceptibilities.
Brook I
Antimicrob Agents Chemother; 1993 May; 37(5):997-1000. PubMed ID: 8517727
[TBL] [Abstract][Full Text] [Related]
20. Cephalosporin-resistance in the Bacteroides fragilis group and the effect of clavulanic acid.
Maskell JP; Nasu M; Williams JD
J Antimicrob Chemother; 1984 Jan; 13(1):23-30. PubMed ID: 6607916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
